Zynerba Pharmaceuticals, Inc. - FORM S-1 - EX-16.1 - June 30, 2015

Attached files

file filename
S-1 - S-1 - Zynerba Pharmaceuticals, Inc.a2223882zs-1.htm
EX-10.19(E) - EX-10.19(E) - Zynerba Pharmaceuticals, Inc.a2223882zex-10_19e.htm
EX-23.1 - EX-23.1 - Zynerba Pharmaceuticals, Inc.a2223882zex-23_1.htm
EX-10.9 - EX-10.9 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_9.htm
EX-10.7 - EX-10.7 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_7.htm
EX-10.18 - EX-10.18 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_18.htm
EX-10.15 - EX-10.15 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_15.htm
EX-4.2 - EX-4.2 - Zynerba Pharmaceuticals, Inc.a2223882zex-4_2.htm
EX-10.12 - EX-10.12 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_12.htm
EX-10.11(A) - EX-10.11(A) - Zynerba Pharmaceuticals, Inc.a2223882zex-10_11a.htm
EX-10.25 - EX-10.25 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_25.htm
EX-10.10 - EX-10.10 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_10.htm
EX-10.3 - EX-10.3 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_3.htm
EX-3.1 - EX-3.1 - Zynerba Pharmaceuticals, Inc.a2223882zex-3_1.htm
EX-10.1 - EX-10.1 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_1.htm
EX-3.3 - EX-3.3 - Zynerba Pharmaceuticals, Inc.a2223882zex-3_3.htm
EX-10.8 - EX-10.8 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_8.htm
EX-10.21 - EX-10.21 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_21.htm
EX-10.24 - EX-10.24 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_24.htm
EX-10.11(B) - EX-10.11(B) - Zynerba Pharmaceuticals, Inc.a2223882zex-10_11b.htm
EX-10.2(B) - EX-10.2(B) - Zynerba Pharmaceuticals, Inc.a2223882zex-10_2b.htm
EX-10.19(A) - EX-10.19(A) - Zynerba Pharmaceuticals, Inc.a2223882zex-10_19a.htm
EX-10.19(C) - EX-10.19(C) - Zynerba Pharmaceuticals, Inc.a2223882zex-10_19c.htm
EX-10.17 - EX-10.17 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_17.htm
EX-10.22 - EX-10.22 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_22.htm
EX-10.11(C) - EX-10.11(C) - Zynerba Pharmaceuticals, Inc.a2223882zex-10_11c.htm
EX-10.2(A) - EX-10.2(A) - Zynerba Pharmaceuticals, Inc.a2223882zex-10_2a.htm
EX-10.6 - EX-10.6 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_6.htm
EX-10.26 - EX-10.26 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_26.htm
EX-10.14 - EX-10.14 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_14.htm
EX-10.16 - EX-10.16 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_16.htm
EX-10.5 - EX-10.5 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_5.htm
EX-10.4 - EX-10.4 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_4.htm
EX-10.19(D) - EX-10.19(D) - Zynerba Pharmaceuticals, Inc.a2223882zex-10_19d.htm
EX-10.23 - EX-10.23 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_23.htm
EX-10.13 - EX-10.13 - Zynerba Pharmaceuticals, Inc.a2223882zex-10_13.htm

Exhibit 16.1

 

January 12, 2015

 

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

 

Ladies and Gentlemen:

 

We have read the section under the heading “Changes in and Disagreements with Accountants on Accounting and Financial Disclosure” in the Registration Statement on Form S-1 dated January 12, 2015, of Zynerba Pharmaceuticals, Inc. and are in agreement with the statements contained in therein.

 

 

Very truly yours,

 

 

 

 

 

/s/ Mountjoy Chilton Medley LLP

 

 

 

Mountjoy Chilton Medley LLP

 


Zynerba Pharmaceuticals, Inc. Reports